At the moment, the use of such drugs is almost exclusively limited to people with a clear medical need to lose weight
IGF-1 LR3, or Long-R3-IGF-1, is a lab-made version of insulin-like growth factor-1
My clinical research company, Virginia Research Center, has studied GLP-1s for both weight loss and cardiovascular risk reductiongiving me a unique perspective on how they can transform health beyond the scale
Authors contributions RS conceived and designed the experiments
Circulating pro-inflammatory cytokines, like TNF- and IL-1, can directly increase BBB permeability by decreasing the expression of tight junction proteins (e.g., occludin, claudins) between cerebral endothelial cells (Lee and Giuliani, 2019